Cv Invus, - Net Worth and Insider Trading

Cv Invus, Net Worth

The estimated net worth of Cv Invus, is at least $64 Million dollars as of 2024-05-01. Cv Invus, is the Director, 10% Owner of Lexicon Pharmaceuticals Inc and owns about 40,450,637 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $64 Million. Details can be seen in Cv Invus,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cv Invus, has not made any transactions after 2012-10-23 and currently still holds the listed stock(s).

Transaction Summary of Cv Invus,

To

Cv Invus, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cv Invus, owns 2 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , and eHealth Inc (EHTH) .

Click here to see the complete history of Cv Invus,’s form 4 insider trades.

Insider Ownership Summary of Cv Invus,

Ticker Comapny Transaction Date Type of Owner
LXRX Lexicon Pharmaceuticals Inc 2020-12-31 director & 10 percent owner
EHTH eHealth Inc 2006-10-12 10 percent owner

Cv Invus, Latest Holdings Summary

Cv Invus, currently owns a total of 1 stock. Cv Invus, owns 40,450,637 shares of Lexicon Pharmaceuticals Inc (LXRX) as of October 23, 2012, with a value of $64 Million.

Latest Holdings of Cv Invus,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LXRX Lexicon Pharmaceuticals Inc 2012-10-23 40,450,637 1.58 63,912,006

Holding Weightings of Cv Invus,


Cv Invus, Form 4 Trading Tracker

According to the SEC Form 4 filings, Cv Invus, has made a total of 0 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 428,571 shares on October 23, 2012, which cost Cv Invus, around $7 Million.

Insider Trading History of Cv Invus,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cv Invus, Trading Performance

GuruFocus tracks the stock performance after each of Cv Invus,'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cv Invus, is 2.79%. GuruFocus also compares Cv Invus,'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Cv Invus, within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cv Invus,'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cv Invus,

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.07
Relative Return to S&P 500(%) -18.79

Cv Invus, Ownership Network

Ownership Network List of Cv Invus,

No Data

Ownership Network Relation of Cv Invus,


Cv Invus, Owned Company Details

What does Lexicon Pharmaceuticals Inc do?

Who are the key executives at Lexicon Pharmaceuticals Inc?

Cv Invus, is the director & 10 percent owner of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .

Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary

Over the past 18 months, Cv Invus, made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .

In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.

Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lexicon Pharmaceuticals Inc Insider Transactions

No Available Data

Cv Invus, Mailing Address

Above is the net worth, insider trading, and ownership report for Cv Invus,. You might contact Cv Invus, via mailing address: C/o The Invus Group, Llc, 750 Lexington Avenue, 30th Floor, New York Ny 10022.

Discussions on Cv Invus,

No discussions yet.